Home

Press Releases

Biotech Leader Provides Testimony on Bioethical Issues in International Clinical Trials
November 17 2011

A timely and consistent regulatory process will ultimately result in medical treatments...

BIO Welcomes Recommendations on Synthetic Biology from Presidential Commission for the Study of Bioethical Issues
December 16 2010
BIO Hails Court of Appeals Action to Lift Injunction on Embryonic Stem Cell Research
September 29 2010
BIO Comments on Court Injunction Blocking Federal Funding of Embryonic Stem Cell Research
August 24 2010
Synthetic Biology and its Practical Applications to Be Highlighted at World Congress on Industrial Biotechnology and Bioprocessing
May 24 2010
BIO Applauds President Obama’s Action to Expand Federal Funding of Embryonic Stem Cell Research
March 9 2009
Incentives to Develop Medicines for Neglected Diseases Highlighted at 2008 BIO International Convention
June 18 2008
BIO Commends Senate for Passage of Stem Cell Research Enhancement Act
April 12 2007
AHA AND BIO FORM COALITION
June 30 1999
BIO Urges President's Bioethics Advisory Panel To Consider Issues Raised By Stem Cell Research
November 12 1998
BIO Welcomes Verification of Dolly's Cloning, Stands by Ban on Human Cloning
July 22 1998
Senate Votes Down Effort to Expedite Ban on Human Cloning
February 11 1998
BIO Responds to Cloning Report
January 7 1998
BIO Supports Ban on Cloning of Humans, Seeks Medical Research Protection
June 7 1997

Letters, Testimony & Comments

BIO Statement to the Presidential Commission for the Study of Bioethical Issues: Principles Regarding Ethical Performance of International Clinical Trials
November 16 2011
Recent reports have raised concerns about how clinical trials are being performed in other countries, particularly in the developing world.
BIO Comments, National Institutes of Health: Promoting Objectivity in Research for Which Public Health Service Funding is Sought and Responsible Prospective Contractors
July 7 2009
 BIO thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the advanced notice of proposed rulemaking regarding conflict of interest in federally funded medical research, published in the Federal Register on May 8, 2009.
BIO Comments, Draft National Institutes of Health Guidelines for Human Stem Cell Research
May 27 2009
The Biotechnology Industry Organization (BIO) thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the draft guidelines for human stem cell research, published in the Federal Register on April 23, 2009.
The Stem Cell Research Enhancement Act
June 6 2007
As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s support for S. 5, the Stem Cell Research Enhancement Act.
BIO Support for S.5, the Stem Cell Research Enhancement Act
April 10 2007
As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s support for S. 5, the Stem Cell Research Enhancement Act.  
More Letters, Testimony & Comments →